Reports
Reports
Sale
The global hyaluronic acid based dermal fillers market size was valued at USD 4.46 billion in 2023, driven by the rising geriatric population, facial ageing, and the inclination towards improving physical appearance along with the rise in demand for wrinkle correction treatments are accelerating the market expansion. The market is estimated to grow at a CAGR of 7.1% during the forecast period 2024-2032 to attain a value of USD 8.26 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on application, the demand for wrinkle correction treatment is expected to grow in the forecast period. The rising geriatric population, facial ageing, and the inclination towards improving physical appearance are accelerating the market expansion. The environmental and lifestyle factors such as smoking, heredity, psychological stress, and occupational and recreational sun exposure are leading to a rise in moderate to severe wrinkle cases in adults, thereby leading to a wider adoption of cosmetic treatments like hyaluronic acid based dermal fillers. The new filler substances such as hyaluronic acid are increasingly being utilised by health care professionals and dermatologists because of their long-term effects when compared to collagen-based dermal fillers. The repeated injections of hyaluronic acid result in the increased natural production of collagen by the body. Additionally, the availability of different hyaluronic acid based wrinkle dermal fillers like Belotero Balance, Juvederm Voluma XC, Juvederm Ultra X, Juvederm Volbella XC, and others is bolstering the market growth. The development of new hyaluronic acid based dermal fillers to reduce wrinkles are likely to aid the market growth over the forecast period.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Hyaluronic acid based dermal filler is a temporary cosmetic treatment that is done by injecting hyaluronic acid into the skin through a needle or cannula. The treatment improves the skin's contour and reduces depression in the skin due to scars, injury, or lines. Hyaluronic acid is naturally present throughout the body, and it attracts water, which allows the skin to become more hydrated.
The market for hyaluronic acid based dermal fillers, by product, is bifurcated into:
Based on application, the market is segmented into:
On the basis of end use, the market is divided into:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The regional markets for hyaluronic acid based dermal fillers can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The rising need to enhance one’s physical appearance to boost self-esteem is significantly catalysing the market growth of hyaluronic acid based dermal fillers. The rapid development of cosmetic clinics, growing awareness about hyaluronic acid based dermal fillers, and the improved living standards of the population are playing a critical role in the market development. There is a rising inclination towards hyaluronic acid based dermal fillers as they serve as a non-invasive method of augmenting lips and chin, creating the appearance of a stronger jawline, or reducing asymmetries in the nose. Thus, the safety associated with the procedure and mild side effects that can be resolved without treatment are invigorating the market expansion. The approval of new hyaluronic acid based dermal fillers by government organisations is providing a further impetus to the market growth. For instance, in December 2021, the US Food and Drug Administration (FDA) approved RHA Redensity developed by Teoxane, a Swiss hyaluronic acid product manufacturing company. RHA Redensity reduces moderate to severe wrinkles in adults aged 22 years and older. The efforts made by the market players for developing cutting-edge technologies, like Advanced Thixotropic Technology (ATT), to achieve the highest quality products and outstanding treatment results are expected to augment the market growth over the forecast period.
The report gives a detailed analysis of the following key players in the global hyaluronic acid based dermal fillers market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Hyaluronic Acid Based Dermal Fillers Market Overview
3.1 Global Hyaluronic Acid Based Dermal Fillers Market Historical Value (2017-2023)
3.2 Global Hyaluronic Acid Based Dermal Fillers Market Forecast Value (2024-2032)
4 Global Hyaluronic Acid Based Dermal Fillers Market Landscape
4.1 Global Hyaluronic Acid Based Dermal Fillers Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Hyaluronic Acid Based Dermal Fillers Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Application
4.2.3 Analysis by End User
5 Global Hyaluronic Acid Based Dermal Fillers Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Hyaluronic Acid Based Dermal Fillers Market Segmentation
6.1 Global Hyaluronic Acid Based Dermal Fillers Market by Product
6.1.1 Market Overview
6.1.2 Single Phase Products
6.1.3 Duplex Products
6.2 Global Hyaluronic Acid Based Dermal Fillers Market by Application
6.2.1 Market Overview
6.2.2 Wrinkle Correction
6.2.3 Scar Treatment
6.2.4 Restoration of Volume
6.2.5 Lip Augmentation
6.2.6 Others
6.3 Global Hyaluronic Acid Based Dermal Fillers Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Speciality Dermatology Clinics
6.3.4 Others
6.4 Global Hyaluronic Acid Based Dermal Fillers Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Hyaluronic Acid Based Dermal Fillers Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Hyaluronic Acid Based Dermal Fillers Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Hyaluronic Acid Based Dermal Fillers Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Hyaluronic Acid Based Dermal Fillers Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Hyaluronic Acid Based Dermal Fillers Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Allergan Aesthetics
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Merz Pharma GmbH & Co. KGaA
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Sinclair Limited
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Teoxane S.A.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Bio Plus Co., Ltd.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Sculpt Luxury Dermal Fillers Ltd
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 NUVISAN GmbH
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Medicis Aesthetics Holdings, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Genzyme Corp.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Sinclair Pharma
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Bohus Biotech AB
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Anika Therapeutics, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
18 Global Hyaluronic Acid Based Dermal Fillers Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
It is estimated that the global market for hyaluronic acid based dermal fillers reached a value of USD 4.46 billion in 2023.
The market is anticipated to grow at a CAGR of 7.1% during the forecast period of 2024-2032 to reach a value of USD 8.26 billion by 2032.
The major market drivers include the improved living standards, non-invasiveness of hyaluronic acid based dermal fillers, increased product safety, rapid development of cosmetic clinics, and growing adoption by healthcare professionals.
The key trends guiding the growth of the market include the growing importance of physical appearance, increasing approval of hyaluronic acid based dermal fillers by government organisations, and initiatives taken by the key market players to develop high quality products.
The major regions in the market are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The significant products of hyaluronic acid based dermal fillers include single phase and duplex.
The different applications of hyaluronic acid based dermal fillers include wrinkle correction, scar treatment, restoration of volume, and lip augmentation, among others.
The major end uses of hyaluronic acid based dermal fillers include hospitals and speciality dermatology clinics.
The major players in the market are Allergan Aesthetics, Merz Pharma GmbH & Co. KGaA, Sinclair Limited, Teoxane S.A., BioPlus Co., Ltd., and Sculpt Luxury Dermal Fillers Ltd, among others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.